Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 3.300
+0.220 (7.14%)
At close: Jun 25, 2026
Vitrafy Life Sciences Market Cap
Vitrafy Life Sciences has a market cap or net worth of 248.78 million as of June 25, 2026. Its market cap has increased by 216.78% in one year.
Market Cap
248.78M
Enterprise Value
226.33M
Revenue
2.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
Market Cap Chart
Since November 26, 2024, Vitrafy Life Sciences's market cap has increased from 126.42M to 248.78M, an increase of 96.79%. That is a compound annual growth rate of 53.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 248.78M | 204.40% |
| Dec 30, 2025 | 81.73M | -24.71% |
| Dec 31, 2024 | 108.54M | -14.14% |
| Nov 26, 2024 | 126.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cuscal | 985.08M |
| FINEOS Corporation Holdings | 663.83M |
| Tyro Payments | 430.79M |
| Qoria | 300.20M |
| Acusensus | 211.54M |
| Wrkr Ltd | 178.25M |
| Decidr AI Industries | 156.38M |
| EML Payments | 118.54M |